Companies /Healthcare

Pfizer Inc

NYSE: PFE Drug Manufacturers - General
$28.01
▼ $0.29 (−1.02%) today
Markets closed · 4:36pm ET

PFE Coverage

Page 82
4:39pm ET
Investing

Pfizer Recalls Birth Control Pills (PFE)

There is going to be some concerning news if you are on birth control pills made by Pfizer Inc. (NYSE: PFE).  The drug giant is announcing a product recall of birth control…

PFE
Jon C. Ogg
7:17am ET
Health and Healthcare

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s guidance may be getting in the way a bit.  The drug giant…

Jon C. Ogg
2:34pm ET
Investing

Pfizer Gets Okay for New Drug (PFE)

Pfizer Inc. (NYSE: PFE) has received approval from the US Food and Drug Administration to sell its kidney cancer drug, Inlyta, in the US. The drug is expected to generate about $140…

PFE
Paul Ausick
12:45pm ET
Investing

Pfizer Loses Court Case on Menopause Drug (PFE)

A state appeals court in Pennsylvania has sided with two women who filed suit against drugmaker Pfizer Inc. (NYSE: PFE) claiming that the company’s Prempro menopause drug caused their breast cancers. The…

PFE
Paul Ausick